These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15620863)

  • 41. Prevention of postsurgical tissue adhesion by anti-inflammatory drug-loaded pluronic mixtures with sol-gel transition behavior.
    Oh SH; Kim JK; Song KS; Noh SM; Ghil SH; Yuk SH; Lee JH
    J Biomed Mater Res A; 2005 Mar; 72(3):306-16. PubMed ID: 15654699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist.
    Akash MS; Rehman K; Sun H; Chen S
    Pharm Dev Technol; 2014 May; 19(3):278-84. PubMed ID: 23506246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].
    Li XY; Zhu ZJ; Cheng AY
    Yao Xue Xue Bao; 2008 Feb; 43(2):208-13. PubMed ID: 18507351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inulin disposition following intramuscular administration of an inulin/poloxamer gel matrix.
    Johnston TP; Miller SC
    J Parenter Sci Technol; 1989; 43(6):279-86. PubMed ID: 2600734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of lidocaine gels for enhanced local anesthetic action.
    Shin SC; Cho CW; Yang KH
    Int J Pharm; 2004 Dec; 287(1-2):73-8. PubMed ID: 15541914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels.
    Yu Z; Guo F; Guo Y; Zhang Z; Wu F; Luo X
    PLoS One; 2017; 12(3):e0173949. PubMed ID: 28350799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Injectable thermosensitive gelling delivery system for the sustained release of lidocaine.
    Svirskis D; Chandramouli K; Bhusal P; Wu Z; Alphonso J; Chow J; Patel D; Ramakrishna R; Yeo SJ; Stowers R; Hill A; Munro J; Young SW; Sharma M
    Ther Deliv; 2016 Jun; 7(6):359-68. PubMed ID: 27250538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [In vitro and in vivo biodegradation of sustained-release vehicle poloxamer 407 in situ gel].
    Feng H; Sun J; Jiang P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jan; 22(1):28-31. PubMed ID: 18338567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
    Jannin V; Pochard E; Chambin O
    Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled release of doxorubicin from thermosensitive poly(organophosphazene) hydrogels.
    Kang GD; Cheon SH; Song SC
    Int J Pharm; 2006 Aug; 319(1-2):29-36. PubMed ID: 16677786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
    Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
    Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and characterization of reactive poloxamer 407s for biomedical applications.
    Niu G; Du F; Song L; Zhang H; Yang J; Cao H; Zheng Y; Yang Z; Wang G; Yang H; Zhu S
    J Control Release; 2009 Aug; 138(1):49-56. PubMed ID: 19409430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanistic studies on release of large and small molecules from biodegradable SiO2.
    Viitala R; Jokinen M; Rosenholm JB
    Int J Pharm; 2007 May; 336(2):382-90. PubMed ID: 17292572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of DMSO on micellization, gelation and drug release profile of Poloxamer 407.
    Ur-Rehman T; Tavelin S; Gröbner G
    Int J Pharm; 2010 Jul; 394(1-2):92-8. PubMed ID: 20472044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery.
    Cafaggi S; Leardi R; Parodi B; Caviglioli G; Russo E; Bignardi G
    J Control Release; 2005 Jan; 102(1):159-69. PubMed ID: 15653142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Eriochrome Black T on the gelatinization of xyloglucan investigated using rheological measurement and release behavior of Eriochrome Black T from xyloglucan gel matrices.
    Hirun N; Tantishaiyakul V; Pichayakorn W
    Int J Pharm; 2010 Mar; 388(1-2):196-201. PubMed ID: 20074631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block.
    Paavola A; Yliruusi J; Kajimoto Y; Kalso E; Wahlström T; Rosenberg P
    Pharm Res; 1995 Dec; 12(12):1997-2002. PubMed ID: 8786979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of organogels as oral controlled release formulations of hydrophilic drugs.
    Iwanaga K; Kawai M; Miyazaki M; Kakemi M
    Int J Pharm; 2012 Oct; 436(1-2):869-72. PubMed ID: 22766444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.